Full Breakdown
NYU Langone Receives Grand Jury Subpoena Over Gender-Affirming Care for Minors
5/13/2026, 1:47:37 AM
Core Event: Federal Grand Jury Subpoena Targeting NYU Langone’s Youth Gender-Affirming Program
NYU Langone Health disclosed on May 12, 2026 that a federal grand jury subpoena issued by the U.S. Department of Justice seeks records of all gender-affirming treatments provided to patients under 18 at its facilities since 2020, as well as the identities of staff involved. The hospital disclosed the subpoena in compliance with New York’s Shield Law, which obligates entities to notify patients before providing protected health information.
Background & Context: Federal Crackdown on Transgender Youth Care
In January 2025, President Donald Trump signed an executive order ending all federal funding for gender-affirming care for minors, labeling the practice a “stain on our Nation’s history” and a “dangerous trend.” The order directed the Justice Department to prioritize investigations of such care. In July 2025, the Justice Department announced it had sent more than 20 administrative subpoenas to doctors and clinics nationwide that provide gender-affirming services to children.
Timeline of Legal Actions
- Jan 2025: Executive order signed by President Trump.
- July 2025: DOJ issues >20 administrative subpoenas to providers.
- May 9 2026: Grand jury subpoenas sent to several institutions, including NYU Langone.
- May 12 2026: NYU Langone publicly acknowledges receipt of the subpoena.
- May 2026: Courts dismiss portions of earlier administrative subpoenas, citing misuse.
- May 2026: DOJ files lawsuit in the Northern District of Texas, securing a court order against Brown Health-operated Rhode Island Hospital.
Data & Statistics
Why It Matters: Implications for Transgender Youth Care and Healthcare Privacy
The subpoena marks the first known use of a grand jury in a criminal probe of gender-affirming care, raising concerns about patient confidentiality, the legal exposure of providers, and the broader availability of medically endorsed treatments for transgender minors.
Official Statements & Responses
NYU Langone emphasized its commitment to patient privacy and indicated it is reviewing its response to the subpoena. A Justice Department spokesperson declined to comment. Federal judges have described portions of the DOJ’s earlier subpoenas as misuse intended to pressure providers.
Criticism & Opposition
Judges have questioned the DOJ’s tactics, suggesting the agency is harassing providers delivering legally sanctioned care. Medical societies argue that barring gender-affirming treatment harms the physical and mental health of transgender youth.
Verbatim Quotes
- “We understand that these developments may be concerning to our patients, providers, and others,” — NYU Langone, statement
- “Please know that NYU Langone takes the privacy of your protected health ?information very seriously and we are evaluating our response to the subpoena.” — NYU Langone, statement
- “stain on our Nation's history” — language from President Trump’s 2025 executive order
- “dangerous trend” — language from President Trump’s 2025 executive order
What’s Next: Ongoing Legal Challenges and Potential Policy Shifts
NYU Langone is reviewing its legal options while the DOJ continues its investigation. Additional court rulings on the admissibility of grand-jury evidence and possible legislative responses in New York and at the federal level are expected in the coming months.
